Robinhood shares gain on Q2 beat, as user and crypto growth accelerate
Investing.com - Harvard Bioscience reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Harvard Bioscience announced earnings per share of $-0.010 on revenue of $26.92M. Analysts polled by Investing.com EPS of $0.067 on revenue of $30.27M.
Harvard Bioscience 's are down 16% and is trading at $2.420 , still down 70.20% from its 52 week high of $8.12 set on Monday, November 15, 2021.
Harvard Bioscience follows other major Healthcare sector earnings this month
Harvard Bioscience's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar